Literature DB >> 15890509

Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management.

Maria C Zoia1, Angelo G Corsico, Massimiliano Beccaria, Roberta Guarnone, Gabriella Cervio, Renato Testi, Maria A Bressan, Ernesto Pozzi, Isa Cerveri.   

Abstract

Chronic obstructive pulmonary disease (COPD) exacerbations could represent an opportunity for pro-active COPD management rather than mere treatment if previously unknown disease is discovered; the extent of underdiagnosis and undertreatment of COPD in patients attending an emergency department (ED) with an exacerbation is not known. During 2002, we recalled 131 COPD patients in stable conditions, 4-8 weeks after they had attended the ED or been discharged from our University Hospital (North-West of Italy). Information on diagnosis and management prior to the ED attendance were collected; spirometry and arterial blood gas analyses were performed. One-third of patients had never been diagnosed and treated even though 83% of them had moderate-to-very-severe COPD and about 30% already had respiratory failure. Only 20% had received information on the nature of the disease and none had received a written action plan. Only 60% were receiving long-acting bronchodilators and 41% of patients with respiratory failure were receiving long-term oxygen. A substantial number of undiagnosed and untreated patients with moderate-to-very-severe COPD came to our attention through an exacerbation. This enforces the importance of exacerbations as the starting point of pro-active COPD management and of the ED as a valuable sentinel to identify this subset of patients.

Entities:  

Mesh:

Year:  2005        PMID: 15890509     DOI: 10.1016/j.rmed.2005.03.032

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

Review 1.  Implementing chronic care for COPD: planned visits, care coordination, and patient empowerment for improved outcomes.

Authors:  Len Fromer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-11-21

2.  Patient-Centered Medical Home in chronic obstructive pulmonary disease.

Authors:  Gabriel Ortiz; Len Fromer
Journal:  J Multidiscip Healthc       Date:  2011-10-25

3.  Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation.

Authors:  Eva Balcells; Elena Gimeno-Santos; Jordi de Batlle; Maria Antonia Ramon; Esther Rodríguez; Marta Benet; Eva Farrero; Antoni Ferrer; Stefano Guerra; Jaume Ferrer; Jaume Sauleda; Joan A Barberà; Àlvar Agustí; Robert Rodriguez-Roisin; Joaquim Gea; Josep M Antó; Judith Garcia-Aymerich
Journal:  BMC Pulm Med       Date:  2015-01-17       Impact factor: 3.317

4.  The complexity of managing COPD exacerbations: a grounded theory study of European general practice.

Authors:  Mette Bech Risør; Mark Spigt; R Iversen; M Godycki-Cwirko; N Francis; A Altiner; E Andreeva; K Kung; H Melbye
Journal:  BMJ Open       Date:  2013-12-05       Impact factor: 2.692

5.  Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists.

Authors:  Vamsi Bollu; Annie Guérin; Geneviève Gauthier; Robert Hiscock; Eric Q Wu
Journal:  Drugs Real World Outcomes       Date:  2017-03

6.  Underdiagnosis of obstructive lung disease: findings from the French CONSTANCES cohort.

Authors:  Marie-Christine Delmas; Laetitia Bénézet; Céline Ribet; Yuriko Iwatsubo; Marie Zins; Rachel Nadif; Nicolas Roche; Bénédicte Leynaert
Journal:  BMC Pulm Med       Date:  2021-10-14       Impact factor: 3.317

7.  Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.

Authors:  Eulàlia Borrell; Mar Rodríguez; Pere Torán; Laura Muñoz; Guillem Pera; Núria Montellà; Mònica Monteagudo; Magalí Urrea; Yolanda Puigfel; Antonio Negrete; Xavier Mezquiriz; Cristina Domènech; Anna Lacasta; Ma Llum García; Sandra Maneus; Glòria Tintoré
Journal:  BMC Public Health       Date:  2009-01-09       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.